Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Merus N V | 811,021 | 741,972 | -69,049 | $34.14M | $39.03M | 7.99% | +$4.89M |
| Akero Therapeutics Inc | 719,992 | 713,811 | -6,181 | $29.15M | $38.09M | 7.80% | +$8.94M |
| Verona Pharma PlcADS | 545,872 | 358,297 | -187,575 | $34.66M | $33.89M | 6.94% | -$769.7K |
| UroGen Pharma Ltd.(URGN) | 1,381,158 | 2,022,482 | +641,324 | $15.28M | $27.71M | 5.67% | +$12.43M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 337,605 | 400,772 | +63,167 | $17.88M | $25.32M | 5.18% | +$7.44M |
| Insmed Incorporated(INSM) | 321,366 | 249,060 | -72,306 | $24.52M | $25.07M | 5.13% | +$548.4K |
| Kalvista Pharmaceuticals Inc | 1,698,984 | 1,832,171 | +133,187 | $19.61M | $20.71M | 4.24% | +$1.11M |
| Neurocrine Biosciences, Inc.(NBIX) | 72,583 | 162,969 | +90,386 | $8.03M | $20.48M | 4.19% | +$12.46M |
| 89bio Inc | 1,510,498 | 2,037,087 | +526,589 | $10.98M | $20.00M | 4.09% | +$9.02M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 2,060,240 | 1,800,829 | -259,411 | $11.50M | $18.28M | 3.74% | +$6.78M |
| Nuvalent Inc | 439,018 | 235,583 | -203,435 | $31.14M | $17.97M | 3.68% | -$13.16M |
| Soleno Therapeutics Inc | 166,417 | 204,591 | +38,174 | $11.89M | $17.14M | 3.51% | +$5.25M |
| Ascendis Pharma A/SADR(ASND) | 75,751 | 86,552 | +10,801 | $11.81M | $14.94M | 3.06% | +$3.13M |
| CG Oncology, Inc.(CGON) | 0 | 541,034 | +541,034 | $0 | $14.07M | 2.88% | +$14.07M |
| Veracyte, Inc.(VCYT) | 633,832 | 448,495 | -185,337 | $18.79M | $12.12M | 2.48% | -$6.67M |
| Scholar Rock Holding Corporation(SRRK) | 0 | 341,010 | +341,010 | $0 | $12.08M | 2.47% | +$12.08M |
| Avidity Biosciences Inc | 411,312 | 410,000 | -1,312 | $12.14M | $11.64M | 2.38% | -$497.9K |
| Vaxcyte, Inc.(PCVX) | 0 | 287,796 | +287,796 | $0 | $9.36M | 1.91% | +$9.36M |
| Pfizer Inc.(PFE) | 0 | 344,338 | +344,338 | $0 | $8.35M | 1.71% | +$8.35M |
| Helix Acquisition Corp IiCL A | 613,393 | 613,393 | 0 | $6.93M | $6.51M | 1.33% | -$417.1K |
| Gossamer Bio, Inc.(GOSS) | 6,320,684 | 5,146,782 | -1,173,902 | $6.95M | $6.33M | 1.30% | -$622.2K |
| Metsera Inc | 112,759 | 207,581 | +94,822 | $3.07M | $5.91M | 1.21% | +$2.84M |
| Elutia Inc.CL A(ELUT) | 2,670,056 | 2,761,684 | +91,628 | $6.76M | $5.47M | 1.12% | -$1.29M |
| Compugen Ltd.(CGEN) | 2,895,430 | 3,033,879 | +138,449 | $4.23M | $5.40M | 1.11% | +$1.17M |
| TELA Bio, Inc.(TELA) | 2,771,288 | 2,779,795 | +8,507 | $3.38M | $5.39M | 1.10% | +$2.01M |
| Abeona Therapeutics Inc.(ABEO) | 0 | 917,898 | +917,898 | $0 | $5.21M | 1.07% | +$5.21M |
| Cidara Therapeutics Inc | 0 | 103,943 | +103,943 | $0 | $5.06M | 1.04% | +$5.06M |
| Celldex Therapeutics, Inc.(CLDX) | 205,962 | 198,441 | -7,521 | $3.74M | $4.04M | 0.83% | +$300.1K |
| Aardvark Therapeutics Inc | 119,496 | 286,807 | +167,311 | $897.4K | $3.88M | 0.79% | +$2.98M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 0 | 82,023 | +82,023 | $0 | $3.87M | 0.79% | +$3.87M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 1,309,224 | 402,964 | -906,260 | $16.08M | $3.77M | 0.77% | -$12.31M |
| Structure Therapeutics IncADS | 188,069 | 175,636 | -12,433 | $3.26M | $3.64M | 0.75% | +$387.2K |
| Cerus Corporation(CERS) | 2,456,537 | 2,488,291 | +31,754 | $3.41M | $3.51M | 0.72% | +$93.9K |
| Erasca, Inc.(ERAS) | 7,367,996 | 2,569,591 | -4,798,405 | $10.09M | $3.26M | 0.67% | -$6.83M |
| Compass Therapeutics, Inc.(CMPX) | 874,869 | 1,249,781 | +374,912 | $1.66M | $3.25M | 0.67% | +$1.59M |
| Sionna Therapeutics, Inc.(SION) | 114,138 | 186,015 | +71,877 | $1.19M | $3.23M | 0.66% | +$2.03M |
| Benitec Biopharma Inc.(BNTC) | 250,000 | 253,234 | +3,234 | $3.25M | $2.96M | 0.61% | -$289.7K |
| Trevi Therapeutics, Inc.(TRVI) | 530,000 | 539,587 | +9,587 | $3.33M | $2.95M | 0.60% | -$382.2K |
| uniQure N.V.SHS(QURE) | 203,400 | 202,565 | -835 | $2.16M | $2.82M | 0.58% | +$667.7K |
| Kiniksa Pharmaceuticals International, plcCL A(KNSA) | 88,215 | 75,959 | -12,256 | $1.96M | $2.10M | 0.43% | +$142.5K |
| Oruka Therapeutics, Inc.(ORKA) | 0 | 165,389 | +165,389 | $0 | $1.85M | 0.38% | +$1.85M |
| Dianthus Therapeutics, Inc.(DNTH) | 190,334 | 95,806 | -94,528 | $3.45M | $1.78M | 0.37% | -$1.67M |
| Tourmaline Bio Inc | 0 | 109,257 | +109,257 | $0 | $1.75M | 0.36% | +$1.75M |
| Mineralys Therapeutics, Inc.(MLYS) | 338,354 | 115,282 | -223,072 | $5.37M | $1.56M | 0.32% | -$3.81M |
| Kodiak Sciences Inc.(KOD) | 441,807 | 401,540 | -40,267 | $1.24M | $1.50M | 0.31% | +$258.5K |
| Delcath Systems, Inc.(DCTH) | 191,470 | 103,026 | -88,444 | $2.44M | $1.40M | 0.29% | -$1.04M |
| Mersana Therapeutics Inc | 3,088,505 | 3,128,421 | +39,916 | $1.06M | $926.0K | 0.19% | -$137.1K |
| Radiopharm Theranostics LimitedADS(RADX) | 187,406 | 187,406 | 0 | $901.4K | $869.6K | 0.18% | -$31.9K |
| Modular Med Inc | 958,881 | 710,363 | -248,518 | $1.05M | $529.2K | 0.11% | -$516.0K |
| Praxis Precision Medicines, Inc.(PRAX) | 166,074 | 10,000 | -156,074 | $6.29M | $420.5K | 0.09% | -$5.87M |
| Fractyl Health, Inc.(GUTS) | 237,448 | 202,590 | -34,858 | $282.6K | $328.2K | 0.07% | +$45.6K |
| Biodesix, Inc.(BDSX) | 4,098,406 | 1,070,367 | -3,028,039 | $2.56M | $302.1K | 0.06% | -$2.26M |
| Sagimet Biosciences Inc.COM SER A(SGMT) | 0 | 37,539 | +37,539 | $0 | $286.0K | 0.06% | +$286.0K |
| Enliven Therapeutics Inc | 0 | 10,000 | +10,000 | $0 | $200.6K | 0.04% | +$200.6K |
| Centessa Pharmaceuticals PlcADS | 232,758 | 5,000 | -227,758 | $3.35M | $65.7K | 0.01% | -$3.28M |
| Nektar Therapeutics(NKTR) | 0 | 346 | +346 | $0 | $8.9K | 0.00% | +$8.9K |
| Rocket Pharmaceuticals, Inc.W EXP 09 02 202(RCKT) | 104,828 | 104,828 | 0 | $4.9K | $3.0K | 0.00% | -$1.9K |
| ABIVAX Société AnonymeADS(ABVX) | 210,901 | 0 | -210,901 | $1.32M | $0 | — | -$1.32M |
| Alkermes plcSHS(ALKS) | 124,871 | 0 | -124,871 | $4.12M | $0 | — | -$4.12M |
| Avadel Pharmaceuticals Plc | 39,366 | 0 | -39,366 | $308.2K | $0 | — | -$308.2K |
| Blueprint Medicines Corp | 37,345 | 0 | -37,345 | $3.31M | $0 | — | -$3.31M |
| BridgeBio Pharma, Inc.(BBIO) | 111,000 | 0 | -111,000 | $3.84M | $0 | — | -$3.84M |
| C4 Therapeutics, Inc.(CCCC) | 882,300 | 0 | -882,300 | $1.41M | $0 | — | -$1.41M |
| Disc Medicine, Inc.(IRON) | 236,471 | 0 | -236,471 | $11.74M | $0 | — | -$11.74M |
| Gilead Sciences, Inc.(GILD) | 62,029 | 0 | -62,029 | $6.95M | $0 | — | -$6.95M |
| InflaRx N.V.(IFRX) | 1,161,567 | 0 | -1,161,567 | $1.18M | $0 | — | -$1.18M |
| KALA BIO, Inc.(KALA) | 246,079 | 0 | -246,079 | $1.41M | $0 | — | -$1.41M |
| Kura Oncology, Inc.(KURA) | 581,369 | 0 | -581,369 | $3.84M | $0 | — | -$3.84M |
| Liquidia Corporation(LQDA) | 214,057 | 0 | -214,057 | $3.16M | $0 | — | -$3.16M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 10,344 | 0 | -10,344 | $3.43M | $0 | — | -$3.43M |
| Ocular Therapeutix, Inc.(OCUL) | 551,570 | 0 | -551,570 | $4.04M | $0 | — | -$4.04M |
| PTC Therapeutics, Inc.(PTCT) | 60,389 | 0 | -60,389 | $3.08M | $0 | — | -$3.08M |
| Solid Biosciences Inc | 452,239 | 0 | -452,239 | $1.67M | $0 | — | -$1.67M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 81,331 | 0 | -81,331 | $4.18M | $0 | — | -$4.18M |
| Travere Therapeutics, Inc.(TVTX) | 408,849 | 0 | -408,849 | $7.33M | $0 | — | -$7.33M |
| Unicycive Therapeutics Inc | 2,413,489 | 0 | -2,413,489 | $1.39M | $0 | — | -$1.39M |
| Vaxart, Inc.(VXRT) | 683,825 | 0 | -683,825 | $278.3K | $0 | — | -$278.3K |
| Wave Life Sciences, Inc.SHS(WVE) | 1,050,374 | 0 | -1,050,374 | $8.49M | $0 | — | -$8.49M |
| Xenon Pharmaceuticals Inc.(XENE) | 10,121 | 0 | -10,121 | $339.6K | $0 | — | -$339.6K |